Precipio Inc./$PRPO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Precipio Inc.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Ticker
$PRPO
Sector
Primary listing
Employees
66
Headquarters
Website
Precipio Inc. Metrics
BasicAdvanced
$40m
-
-$0.55
-
-
Price and volume
Market cap
$40m
52-week high
$33.63
52-week low
$10.50
Average daily volume
33k
Financial strength
Current ratio
1.557
Quick ratio
1.205
Long term debt to equity
19.948
Total debt to equity
24.649
Interest coverage (TTM)
-28.11%
Profitability
EBITDA (TTM)
-0.356
Gross margin (TTM)
43.71%
Net profit margin (TTM)
-3.57%
Operating margin (TTM)
-6.86%
Revenue per employee (TTM)
$390,000
Management effectiveness
Return on assets (TTM)
-5.74%
Return on equity (TTM)
-7.13%
Valuation
Price to revenue (TTM)
1.45
Price to book
2.82
Price to tangible book (TTM)
11.44
Price to free cash flow (TTM)
67.49
Free cash flow yield (TTM)
1.48%
Free cash flow per share (TTM)
0.331
Growth
Revenue change (TTM)
28.97%
Earnings per share change (TTM)
-73.61%
3-year revenue growth (CAGR)
38.22%
3-year earnings per share growth (CAGR)
-61.04%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs